370 related articles for article (PubMed ID: 17724374)
1. Biotransformation and transport of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in bile duct-cannulated wild-type and Mrp2/Abcc2-deficient (TR ) Wistar rats.
Leslie EM; Ghibellini G; Nezasa K; Brouwer KL
Carcinogenesis; 2007 Dec; 28(12):2650-6. PubMed ID: 17724374
[TBL] [Abstract][Full Text] [Related]
2. Biliary excretion of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in the rat.
Schulze J; Richter E; Binder U; Zwickenpflug W
Carcinogenesis; 1992 Nov; 13(11):1961-5. PubMed ID: 1423863
[TBL] [Abstract][Full Text] [Related]
3. Disposition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in bile duct-cannulated rats: stereoselective metabolism and tissue distribution.
Wu Z; Upadhyaya P; Carmella SG; Hecht SS; Zimmerman CL
Carcinogenesis; 2002 Jan; 23(1):171-9. PubMed ID: 11756238
[TBL] [Abstract][Full Text] [Related]
4. Analysis of human urine for pyridine-N-oxide metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, a tobacco-specific lung carcinogen.
Carmella SG; Borukhova A; Akerkar SA; Hecht SS
Cancer Epidemiol Biomarkers Prev; 1997 Feb; 6(2):113-20. PubMed ID: 9037562
[TBL] [Abstract][Full Text] [Related]
5. Transport of the beta -O-glucuronide conjugate of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) by the multidrug resistance protein 1 (MRP1). Requirement for glutathione or a non-sulfur-containing analog.
Leslie EM; Ito K; Upadhyaya P; Hecht SS; Deeley RG; Cole SP
J Biol Chem; 2001 Jul; 276(30):27846-54. PubMed ID: 11375986
[TBL] [Abstract][Full Text] [Related]
6. Metabolism of a glucuronide conjugate of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in rats.
Atawodi SE; Michelsen K; Richter E
Arch Toxicol; 1994; 69(1):14-7. PubMed ID: 7717849
[TBL] [Abstract][Full Text] [Related]
7. Stereoselective metabolism and tissue retention in rats of the individual enantiomers of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL), metabolites of the tobacco-specific nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK).
Zimmerman CL; Wu Z; Upadhyaya P; Hecht SS
Carcinogenesis; 2004 Jul; 25(7):1237-42. PubMed ID: 14988218
[TBL] [Abstract][Full Text] [Related]
8. Uptake and metabolism of carcinogenic levels of tobacco-specific nitrosamines by Sudanese snuff dippers.
Murphy SE; Carmella SG; Idris AM; Hoffmann D
Cancer Epidemiol Biomarkers Prev; 1994; 3(5):423-8. PubMed ID: 7920210
[TBL] [Abstract][Full Text] [Related]
9. Characterization of a glucuronide metabolite of 4-(methyl-nitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and its dose-dependent excretion in the urine of mice and rats.
Morse MA; Eklind KI; Toussaint M; Amin SG; Chung FL
Carcinogenesis; 1990 Oct; 11(10):1819-23. PubMed ID: 2208595
[TBL] [Abstract][Full Text] [Related]
10. Metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in the patas monkey: pharmacokinetics and characterization of glucuronide metabolites.
Hecht SS; Trushin N; Reid-Quinn CA; Burak ES; Jones AB; Southers JL; Gombar CT; Carmella SG; Anderson LM; Rice JM
Carcinogenesis; 1993 Feb; 14(2):229-36. PubMed ID: 8435864
[TBL] [Abstract][Full Text] [Related]
11. Biotransformation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in lung tissue from mouse, rat, hamster, and man.
Richter E; Engl J; Friesenegger S; Tricker AR
Chem Res Toxicol; 2009 Jun; 22(6):1008-17. PubMed ID: 19408892
[TBL] [Abstract][Full Text] [Related]
12. Cotinine effects on bile flow and biliary NNK elimination.
Meiser H; Atawodi SE; Richter E
Eur J Med Res; 2000 Jun; 5(6):241-6. PubMed ID: 10882639
[TBL] [Abstract][Full Text] [Related]
13. Quantitation of urinary metabolites of a tobacco-specific lung carcinogen after smoking cessation.
Hecht SS; Carmella SG; Chen M; Dor Koch JF; Miller AT; Murphy SE; Jensen JA; Zimmerman CL; Hatsukami DK
Cancer Res; 1999 Feb; 59(3):590-6. PubMed ID: 9973205
[TBL] [Abstract][Full Text] [Related]
14. Metabolism and disposition of 4-(methylnitrosamino)-1-(3-pyridyl)-1- butanone (NNK) in rhesus monkeys.
Meger M; Richter E; Zwickenpflug W; Oehlmann C; Hargaden MB; A-Rahim YI; Vesell ES
Drug Metab Dispos; 1999 Apr; 27(4):471-8. PubMed ID: 10101142
[TBL] [Abstract][Full Text] [Related]
15. Tumorigenicity and metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol enantiomers and metabolites in the A/J mouse.
Upadhyaya P; Kenney PM; Hochalter JB; Wang M; Hecht SS
Carcinogenesis; 1999 Aug; 20(8):1577-82. PubMed ID: 10426810
[TBL] [Abstract][Full Text] [Related]
16. Biotransformation of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in freshly isolated human lung cells.
Smith GB; Castonguay A; Donnelly PJ; Reid KR; Petsikas D; Massey TE
Carcinogenesis; 1999 Sep; 20(9):1809-18. PubMed ID: 10469628
[TBL] [Abstract][Full Text] [Related]
17. Intestinal metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in rats: Sex difference, inducibility and inhibition by phenethylisothiocyanate.
Schulze J; Malone A; Richter E
Carcinogenesis; 1995 Aug; 16(8):1733-40. PubMed ID: 7634397
[TBL] [Abstract][Full Text] [Related]
18. Effect of phenethyl isothiocyanate on the metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by cultured rat lung tissue.
Doerr-O'Rourke K; Trushin N; Hecht SS; Stoner GD
Carcinogenesis; 1991 Jun; 12(6):1029-34. PubMed ID: 2044181
[TBL] [Abstract][Full Text] [Related]
19. Quantitation of pyridylhydroxybutyl-DNA adducts in liver and lung of F-344 rats treated with 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and enantiomers of its metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol.
Upadhyaya P; Kalscheuer S; Hochalter JB; Villalta PW; Hecht SS
Chem Res Toxicol; 2008 Jul; 21(7):1468-76. PubMed ID: 18570389
[TBL] [Abstract][Full Text] [Related]
20. Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in isolated rat lung and liver.
Schrader E; Hirsch-Ernst KI; Richter E; Foth H
Naunyn Schmiedebergs Arch Pharmacol; 1998 Mar; 357(3):336-43. PubMed ID: 9550307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
